Veterinary Medicines

ORBESEAL DRY COW 2.6G INTRAMAMMARY SUSPENSION

Authorised
  • Bismuth subnitrate, heavy
Download as PDF

Identifikazzjoni tal-prodott

Isem tal-mediċina:
ORBESEAL DRY COW 2.6G INTRAMAMMARY SUSPENSION
Orbeseal vet. 2,6 g intramammarie, suspensjon til sinkyr
Sustanza attiva:
Speċi li fuqhom ser jintuża l-prodott:
Metodu ta’ amministrazzjoni:
  • Użu intramammarju

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    2.60
    gram(s)
    /
    1.00
    Syringe
Forma farmaċewtika:
  • Suspensjoni intramammarja
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (cow)
      • Meat and offal
        0
        day
      • Milk
        0
        day
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QG52X
Status legali tal-provvista:
Status tal-awtorizzazzjoni:
  • Valid
Authorised in:
  • Norway
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Bażi ġuridika tal-awtorizzazzjoni tal-prodott:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Zoetis Animal Health ApS
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Cross Vetpharm Group Limited
  • Haupt Pharma Latina S.r.l.
Awtorità responsabbli:
  • Norwegian Medicines Agency
Numru tal-awtorizzazzjoni:
  • 02-1548
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Stat Membru ta’ referenza:
Numru tal-proċedura:
  • FR/V/0341/001
Stati Membri Kkonċernati:

Dokumenti

Sommarju tal-karatteristiċi tal-prodott

Dan id-dokument ma jeżistix f'dan il-lingwa (Malti). Tista 'ssibha f'lingwa oħra hawn taħt.
Norwegian (PDF)
Ippubblikat fuq: 6/06/2023
Niżżel

Fuljett ta’ tagħrif

Dan id-dokument ma jeżistix f'dan il-lingwa (Malti). Tista 'ssibha f'lingwa oħra hawn taħt.
Norwegian (PDF)
Ippubblikat fuq: 6/06/2023
Niżżel
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."